We are live on ! Find out more
LIM

Lagoda Investment Management Portfolio holdings

AUM $162M
1-Year Est. Return 49.7%
This Fund
S&P 500
This Quarter Est. Return
+3.33%
1 Year Est. Return
+49.7%
3 Year Est. Return
+193.16%
5 Year Est. Return
+230.21%
10 Year Est. Return
+1,614.49%
AUM
$375M
AUM Growth
–
Cap. Flow
+$370M
Cap. Flow %
98.82%
Top 10 Hldgs %
68.18%
Holding
47
New
47
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$37.1M
2
REGN icon
Regeneron Pharmaceuticals
REGN
+$36.3M
3
NVO
Novo Nordisk
NVO
+$26.7M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$25.3M
5
BRK.A icon
Berkshire Hathaway Class A
BRK.A
+$24.9M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 46.56%
2 Financials 21.42%
3 Communication Services 6.63%
4 Materials 5.99%
5 Technology 5.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
26
State Street SPDR S&P 500 ETF Trust
SPY
$810B
$321K 0.09%
+1,563
New +$314K
KMX icon
27
CarMax
KMX
$8.34B
$292K 0.08%
+4,380
New +$243K
XEC
28
DELISTED
CIMAREX ENERGY CO
XEC
$186K 0.05%
+1,750
New +$194K
NUE icon
29
Nucor
NUE
$62.5B
$172K 0.05%
+3,500
New +$182K
NATI
30
DELISTED
National Instruments Corp
NATI
$172K 0.05%
+5,540
New +$172K
NTAP icon
31
NetApp
NTAP
$39B
$166K 0.04%
+4,000
New +$166K
CME icon
32
CME Group
CME
$94.8B
$109K 0.03%
+1,232
New +$104K
AAPL icon
33
Apple
AAPL
$4.5T
$104K 0.03%
+3,780
New +$103K
CVX icon
34
Chevron
CVX
$382B
$84K 0.02%
+750
New +$85.2K
PFE icon
35
Pfizer
PFE
$154B
$58K 0.02%
+1,977
New +$56.7K
FIS icon
36
Fidelity National Information Services
FIS
$21.9B
$41K 0.01%
+666
New +$39.1K
RTX icon
37
RTX Corp
RTX
$302B
$40K 0.01%
+550
New +$37.5K
BUD icon
38
AB InBev
BUD
$164B
$38K 0.01%
+340
New +$37.7K
ABBV icon
39
AbbVie
ABBV
$438B
$32K 0.01%
+491
New +$31K
ABT icon
40
Abbott
ABT
$188B
$29K 0.01%
+640
New +$27.9K
ADM icon
41
Archer Daniels Midland
ADM
$38.8B
$26K 0.01%
+500
New +$24.9K
PSX icon
42
Phillips 66
PSX
$86B
$24K 0.01%
+332
New +$24.5K
GSK icon
43
GSK
GSK
$105B
$21K 0.01%
+400
New +$22.4K
D icon
44
Dominion Energy
D
$59B
$15K ﹤0.01%
+200
New +$14.5K
COP icon
45
ConocoPhillips
COP
$148B
$12K ﹤0.01%
+2,268
New +$158K
ZBH icon
46
Zimmer Biomet
ZBH
$18.7B
$10K ﹤0.01%
+93
New +$9.8K
BMY icon
47
Bristol-Myers Squibb
BMY
$132B
$6K ﹤0.01%
+100
New +$5.64K
1
2

Similar funds

AXA
Accel XI Associates Palo Alto, California $162M AUM
KCPT
Kingstone Capital Partners Texas Frisco, Texas $162M AUM 29.56% 1-Year Est. Return
TFP
Traction Financial Partners Encampment, Wyoming $162M AUM 14.21% 1-Year Est. Return
CWMGO
Capstone Wealth Management Group (Oregon) Bend, Oregon $163M AUM 31.61% 1-Year Est. Return
SWMG
Stillwater Wealth Management Group Juno Beach, Florida $162M AUM
TIAM2
Tru Independence Asset Management 2 Portland, Oregon $163M AUM 18.06% 1-Year Est. Return
GPA
Guerra Pan Advisors Montclair, New Jersey $162M AUM 33.07% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $163M AUM 40.62% 1-Year Est. Return

Lagoda Investment Management's Q4 2014 Portfolio in Review

Q4 2014 is the first quarter with a 13F filing on record for Lagoda Investment Management, which disclosed 47 positions worth $375M. Its ten largest holdings account for 68% of the portfolio.

Its largest position is Alexion Pharmaceuticals: 200,465 shares worth $37.1M.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, followed by Financials and Communication Services.

  • Lagoda Investment Management's largest Q4 2014 buy was Alexion Pharmaceuticals: 200,465 shares worth $37.1M.
  • Lagoda Investment Management's ten largest holdings make up 68% of its $375M portfolio in Q4 2014.
  • Lagoda Investment Management disclosed 47 positions in Q4 2014, its first 13F filing on record.

Based on Lagoda Investment Management's 13F filing for Q4 2014, filed 17 Feb 2015.